Aviva McPherron has joined Orthofix Medical Inc. as president of Global Operations and Quality, overseeing strategy for the company’s operations, manufacturing, regulatory, clinical, and quality teams.
 
McPherron most recently worked at Globus Medical as senior vice president, Clinical Services and Integration, having orchestrated strategic initiatives to drive growth and enhance profitability. In that role, McPherron also led the integration planning and execution for the Globus Medical-NuVasive Inc. merger. Before Globus Medical, McPherron served in roles of increasing responsibility for NuVasive Inc., including chief transformation officer, where she led the strategy to transform the commercial and operational processes, portfolio, and back-office organization to drive company profitability.
 
“We are pleased to have Aviva join our leadership team,” Orthofix President/CEO Massimo Calafiore said. “Her experience and background will be an asset to our strong operations, clinical, regulatory and quality teams to help drive strategies that deliver operational efficiencies and gross margin improvements, both of which are critical to achieving the value of our merger.”
 
Prior to Globus Medical and NuVasive Inc., McPherron held various leadership roles across technology and defense industries.
 
“The merger of Orthofix and SeaSpine has the company well-positioned for growth and success, and I am excited to be joining this team,” McPherron stated. “I look forward to working with the team to foster better coordination and optimization across the company’s operational processes to ensure the best quality products are available for surgeons and their patients.”
 
McPherron earned a bachelor of science degree in mechanical engineering from Stanford University. She serves on the Sharp Healthcare IT Advisory Board and as a member of the San Diego Mesa College Foundation Board.
 
As an inducement to enter into employment with Orthofix, McPherron was granted (i) performance-based vesting restricted stock units that settle into 59,666 shares of common stock at target achievement, (ii) time-based vesting restricted stock units that settle into 29,833 shares of common stock, and (iii) stock options to purchase 68,638 shares of common stock. 
 
Orthofix is a global spine and orthopedics company with a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and a surgical navigation system. Its products are distributed in more than 60 countries worldwide. The company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, Calif., with a focus on spine and biologics product innovation and surgeon education; and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial, and manufacturing footprint also includes facilities and offices in Irvine, Calif.; Toronto, Canada; Sunnyvale, Calif.; Maidenhead, U.K.; Munich, Germany; Paris, France; and São Paulo, Brazil.